The effect of the enzyme inhibitor phenylmethylsulfonyl fluoride on the pharmacological effect of anandamide in the mouse model of cannabimimetic activity

Journal of Pharmacology and Experimental Therapeutics

Volumn 283, Issue 3, 1997, Pages 1138-1143

  Compton, David R ^a   Martin, Billy R ^a,b  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANANDAMIDE; BENZYLSULFONYL FLUORIDE; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; ENZYME INHIBITOR; RIMONABANT;

ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG METABOLISM; HYPOTHERMIA; IMMOBILIZATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TAIL FLICK TEST;

ANALGESICS; ANIMALS; ARACHIDONIC ACIDS; BODY TEMPERATURE; CANNABINOIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MICE; MICE, INBRED ICR; MOTOR ACTIVITY; PHENYLMETHYLSULFONYL FLUORIDE; PIPERIDINES; POLYUNSATURATED ALKAMIDES; PYRAZOLES;

EID: 0031471724     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. ADAMS, I. B., RYAN, W., SINGER, M., THOMAS, B. F., COMPTON, D. R., RAZDAN, R. K. AND MARTIN, B. R.: Evaluation of cannabinoid receptor binding and in vivo activities for anandamide analogs. J. Pharmacol. Exp. Ther. 273: 1172-1181, 1995.
2. CHILDERS, S. R., SEXTON, T. AND ROY, M. B.: Effects of anandamide on cannabinoid receptors in rat brain membranes. Biochem. Pharmacol. 47: 711-715, 1994.
3. DESARNAUD, F., CADAS, H. AND PIOMELLI, D.: Anandamide amidohydrolase activity in rat brain microsomes. J. Biol. Chem. 270: 6030-6035, 1995.
4. DEUTSCH, D. G. AND CHIN, S. A.: Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist. Biochem. Pharmacol. 46: 791-796, 1993.
5. DEVANE, W. A., HANUS, L., BREUER, A., PERTWEE, R. G., STEVENSON, L. A., GRIFFIN, G., GIBSON, D., MANDELBAUM, A., ETINGER, A. AND MECHOULAM, R.: Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258: 1946-1949, 1992.
6. FRIDE, E. AND MECHOULAM, R.: Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent. Eur. J. Pharmacol. 231: 313-314, 1993.
7. HAMPSON, A., HILL, W. A., ZAN-PHILLIPS, M., MAKRIYANNIS, A., LEUNG, E., EGLEN, R. AND BORNHEIM, L.: Anandamide hydroxylation by brain lipoxygenase: Metabolite structures and potencies at the cannabinoid receptor. Biochim. Biophys. Acta 1259: 173-179, 1995.
8. HILLARD, C. J., EDGEMOND, W. AND CAMPBELL, W.: Characterization ligand binding to the cannabinoid receptor of rat brain membranes using a novel method: Application to anandamide. J. Neurochem. 64: 677-683, 1995.
9. JAMES, G. T.: Inactivation of the protease inhibitor phenylmethylsulfonyl fluoride in buffers. Anal. Biochem. 86: 574-579, 1978.
10. MOSS, D. E. AND FAHRNEY, D.: Kinetic analysis of differences in brain acetylcholinesterase from fish or mammalian sources. Biochem. Pharmacol. 27: 2693-2698, 1978.
11. MOSS, D. E., RODRIGUEZ, L. A. AND MCMASTER, S. B.: Comparative behavioral effects of CNS cholinesterase inhibitors. Pharmacol. Biochem. Behav. 22: 479-482, 1985.
12. SMITH, P. B., COMPTON, D. R., WELCH, S. P., RAZDAN, R. K., MECHOULAM, R. AND MARTIN, B. R.: The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice. J. Pharmacol. Exp. Ther. 270: 219-227, 1994.
13. TURINI, P., KUROOKA, S., STEER, M., CORBASCIO, A. N. AND SINGER, T. P.: The action of phenylmethylsulfonyl fluoride on human acetylcholinesterase, chymotrypsin and trypsin. J. Pharmacol. Exp. Ther. 167: 98-104, 1969.
14. WILLOUGHBY, K. A., MOORE, S. F., MARTIN, B. R. AND ELLIS, E. F.: The biodisposition and metabolism of anandamide in mice. J. Pharmacol. Exp. Ther. 282: 243-247, 1997.